tradmap

COSM Cosmos Health Inc.

$0.31 -0.70%

Data as of close

Industrials · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Cosmos Health Inc. (COSM) is an industrial company in the Wholesale-Drugs, Proprietaries & Druggists' Sundries industry, with a market capitalization of $31 million. Shares last traded at $0.31, 61.9% below their 52-week high. Over the past year the stock is down 65.6%. Net profit margin is -33.1%, below the peer median of 0.7%. Revenue grew 19.9% year over year.

Market Cap
$31M
Shares Out
100.6M
EPS (TTM)
-$0.66
P/E (TTM)*
—
P/S Ratio
0.42
P/B Ratio
1.49
Dividend / Share
—
Dividend Yield
—
52-Week High
$0.81
52-Week Low
$0.16
Volume (venue)
21,491
Avg Vol (3m, venue)
45,275.683

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+33.25%
1M
-19.72%
3M
+35.73%
6M
-14.34%
YTD
-38.77%
1Y
-65.60%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
50.86
SMA (50)
$0.30
SMA (200)
$0.31
Price vs SMA50
+1.54%
Price vs SMA200
-1.25%
ATR (14)
$0.03

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$74M
Net Income
-$24M
Gross Margin
10.3%
Operating Margin
-24.9%
Net Margin
-33.1%
Return on Equity
-118.0%
Return on Assets
-39.7%
Current Ratio
1.05
Debt / Equity
0.15
Revenue Growth (YoY)
+19.9%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q2 2026 -$0.10 2026-08-18
Q1 2026 -$0.06 2026-05-20
Q4 2025 (derived) -$0.33 2026-04-15
FY 2025 -$0.63 2026-04-15
Q3 2025 -$0.17 2025-11-14
Q2 2025 -$0.10 2025-08-18

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Wholesale-Drugs, Proprietaries & Druggists' Sundries peers

COSM vs 9 industry peers (Wholesale-Drugs, Proprietaries & Druggists' Sundries), by market cap. Data as of close

P/S vs peers
0.42 / 0.25 med
+66% premium
Net margin vs peers
-33.1% / 0.7% med
below median
1–9 of 9
MCKMcKesson Corporation$116.4B25.360.281.1%+0.30%
CORCencora$64.5B24.570.190.8%+2.11%
CAHCardinal Health$59.2B35.590.240.7%+1.53%
HLFHerbalife Ltd.$1.4B7.750.263.4%+1.68%
NUSNU SKIN ENTERPRISES, INC.$233M—0.17-15.7%+2.36%
COSMCosmos Health Inc.$31M—0.42-33.1%-0.70%
ESYNHWH International Inc.$13M———-6.42%
MEDSDataMeds AI, Inc.$5M———-8.25%
HKPDCellyan Biotechnology Co., Ltd$2M———-12.74%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.